Invacare (IVC) & Inogen (INGN) Financial Analysis

Invacare (NYSE: IVC) and Inogen (NASDAQ:INGN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, profitability and institutional ownership.

Profitability

This table compares Invacare and Inogen’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Invacare -7.92% -14.95% -6.31%
Inogen 8.42% 13.47% 11.17%

Analyst Recommendations

This is a breakdown of recent ratings for Invacare and Inogen, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Invacare 0 1 2 0 2.67
Inogen 0 1 4 0 2.80

Invacare currently has a consensus price target of $16.50, indicating a potential downside of 12.70%. Inogen has a consensus price target of $118.40, indicating a potential downside of 16.08%. Given Invacare’s higher possible upside, research analysts clearly believe Invacare is more favorable than Inogen.

Institutional & Insider Ownership

99.0% of Inogen shares are owned by institutional investors. 2.1% of Invacare shares are owned by insiders. Comparatively, 5.3% of Inogen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Invacare has a beta of 2.53, meaning that its share price is 153% more volatile than the S&P 500. Comparatively, Inogen has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.

Valuation and Earnings

This table compares Invacare and Inogen’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Invacare $966.50 million 0.77 -$76.54 million ($1.93) -9.79
Inogen $249.44 million 12.00 $21.00 million $1.31 107.69

Inogen has lower revenue, but higher earnings than Invacare. Invacare is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks.

Dividends

Invacare pays an annual dividend of $0.05 per share and has a dividend yield of 0.3%. Inogen does not pay a dividend. Invacare pays out -2.6% of its earnings in the form of a dividend.

Summary

Inogen beats Invacare on 11 of the 16 factors compared between the two stocks.

Invacare Company Profile

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and the Asia/Pacific. It offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and K├╝schall brand names; and seating and positioning products. The company also provides lifestyle products, including pressure relieving overlays and mattress replacement systems under the Invacare Softform and microAIR brands; safe resident handling products; residential care and home beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Perfecto2, Perfecto2 V, and Platinum brands; Invacare HomeFill oxygen systems; and Invacare SOLO2 and XPO2 transportable oxygen concentrators. Further, it sells and distributes healthcare furnishings consisting of long-term care beds, case goods, safe patient handling equipment, and other equipment and accessories for long-term care customers. It sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, distributors, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

Inogen Company Profile

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

33,753 Shares in Core-Mark  Acquired by Engineers Gate Manager LP
33,753 Shares in Core-Mark Acquired by Engineers Gate Manager LP
Engineers Gate Manager LP Has $11.45 Million Position in SPDR S&P 500 Trust ETF
Engineers Gate Manager LP Has $11.45 Million Position in SPDR S&P 500 Trust ETF
Schwab Charles Investment Management Inc. Raises Position in First Republic Bank
Schwab Charles Investment Management Inc. Raises Position in First Republic Bank
Engineers Gate Manager LP Acquires Shares of 18,136 LKQ Co.
Engineers Gate Manager LP Acquires Shares of 18,136 LKQ Co.
Engineers Gate Manager LP Invests $734,000 in Teradata Co.  Stock
Engineers Gate Manager LP Invests $734,000 in Teradata Co. Stock
Schwab Charles Investment Management Inc. Grows Stake in AptarGroup, Inc.
Schwab Charles Investment Management Inc. Grows Stake in AptarGroup, Inc.


© 2006-2018 Ticker Report. Google+.